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Prevalence of Lower Urinary Tract Symptoms in Men
Over 40 Years: A Cross-Sectional Study in Samsun
Aim: Lower urinary tract symptoms (LUTS) are a common problem in ageing men. The aim of this study was
to estimate the prevalence of LUTS, as measured by the International Prostate Symptom Score (IPSS), and to
establish the relationship between the IPSS and quality of life (QoL) in different age groups of men over 40
years old living in Samsun city center in northern Turkey.
Materials and Methods: In all, 1860 men aged over 40 years were included in this cross-sectional study.
The Turkish version of the IPSS was applied to all participants using face-to-face interview.
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Results: The median IPSS and QoL were 3 (1-9) and 1 (0-3), and increased from 1.0 (0-4) and 0.0 (0-1) in
the fifth decade to 18.0 (12-26.5) and 4.0 (3-5) in those over 80, respectively. There were statistically
significant differences between the age groups in both IPSS and QoL (P < 0.01). Of the participants, 81.3%
had at least one symptom, the most prevalent of which was nocturia (71.7%). Of the respondents, 29.6%
had moderate-to-severe LUTS as measured by the IPSS, and the increase in the prevalence of moderate-tosevere symptoms with age was statistically important (P < 0.001). Nocturia was found to be the strongest
2
predictor of QoL (r = 0.50, P < 0.001).
Conclusions: The prevalence of LUTS in Turkish elderly men is fairly high and increases with age. This finding
must be considered when resources are planned for medical care. On the other hand, it seems that increased
public awareness is needed to combat the adverse effects of LUTS on QoL.
Key Words: Ageing men, IPSS, LUTS

K›rk Yaﬂ Üstü Erkeklerde Alt Üriner Sistem Semptom S›kl›¤›: Samsun’da
Kesitsel Bir Çal›ﬂma
Amaç: Alt üriner sistem semptomlar› (AÜSS) yaﬂl› erkeklerde s›k görülen sorunlardand›r. Bu çal›ﬂman›n amac›
Uluslararas› Prostat Semptom Skoru (IPSS)’nu kullanarak, Türkiye’nin kuzey illerinden Samsun’da yaﬂayan 40
yaﬂ üstü erkeklerdeki AÜSS s›kl›¤›n› saptamak ve IPSS ile yaﬂam kalitesi (QoL) aras›ndaki iliﬂkiyi belirlemektir.
Yöntem ve Gereç: Kesitsel tipteki bu çal›ﬂmaya 40 yaﬂ üstünde 1860 erkek kat›lm›ﬂ ve kat›l›mc›lara IPSS’nun
Türkçe formu yüz yüze anket yöntemiyle uygulanm›ﬂt›r.
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Bulgular: IPSS ve yaﬂam kalitesi ölçeklerinin skor ortancalar› tüm grupta s›ras›yla 3 (1-9) ve 1 (0-3)
bulunmuﬂtur. Her iki ölçekten al›nan skor ortancalar› 40-49 yaﬂ grubunda s›ras›yla 1.0 (0-4) ve 0.0 (0-1) iken,
80 yaﬂ ve üzerindeki kat›l›mc›larda 18.0 (12-26.5) ve 4.0 (3-5)’e yükselmiﬂtir.Yaﬂ gruplar› aras›nda IPSS ve
QoL skorlar› aç›s›ndan istatistiksel olarak anlaml› fark bulunmuﬂtur (P < 0.01). Kat›l›mc›lar›n %81.3’ünün en
az bir semptomu oldu¤u ve en s›k bildirilen semptomun da noktüri oldu¤u saptanm›ﬂt›r (%71.7). IPSS skoruna
göre de¤erlendirildi¤inde kat›l›mc›lar›n %29.6’s›n›n orta derecede ya da ﬂiddetli AÜSS’unun oldu¤u ve bu
semptomlar›n s›kl›¤›n›n yaﬂla birlikte istatistiksel olarak anlaml› ﬂekilde artt›¤› bulunmuﬂtur. (P < 0.001).
Noktüri yaﬂam kalitesinin en güçlü göstergesi olarak bulunmuﬂtur (r2 = 0.50, P < 0.001).
Sonuç: Bu çal›ﬂmada AÜSS’lar›n›n yaﬂl› Türk erkeklerindeki s›kl›¤›n›n oldukça yüksek oldu¤u ve yaﬂla birlikte
artt›¤› bulunmuﬂtur. Sonuç olarak sa¤l›k hizmetleri kaynak planlamas› yap›l›rken bu bulgular›n göz önünde
bulundurulmas›n›n, AÜSS’lar›n›n yaﬂam kalitesine olan olumsuz etkileriyle mücadele edebilmek için toplumun
fark›ndal›¤›n›n art›r›lmas›n›n gerekti¤i düﬂünülmektedir.
Anahtar Sözcükler: Yaﬂl› erkek, IPSS, Alt üriner sistem semptomlar›
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Introduction
Lower urinary tract symptoms (LUTS), such as urinary
frequency and nocturia, are a common problem in ageing
men, and with the increasing mean age of the general
population, the number of individuals with LUTS is likely
to increase. The term benign prostatic hyperplasia (BPH)
has traditionally been used to describe a constellation of
obstructive and irritative voiding symptoms that occur in
men as they age. Such symptoms may result from various
causes, including prostatic enlargement, and thus the
term LUTS has replaced BPH to describe this symptom
complex (1). The International Prostate Symptom Score
(IPSS) is a recommended method to estimate the
prevalence and severity of LUTS (2).
Estimates of the prevalence of LUTS in the male
population vary considerably depending upon the
definitions and criteria adopted by investigators.
According to two recent multinational population-based
studies, the prevalence of LUTS and/or BPH is 3-10% in
men aged 40-49 years, rising to 24--29% in those aged
70-80 years (3,4). There is only one reported
community-based prevalence study of LUTS in Turkey, in
which the prevalence of moderate-to-severe LUTS was
found as 24.9% in men aged over 40 years (5).
The aim of this study was to estimate the prevalence
of LUTS, as measured by the IPSS, and to establish the
relationship between the IPSS and quality of life (QoL) in
different age groups of men 40-89 years old living in
Samsun city center in northern Turkey.

Materials and Methods
A cross-sectional study was conducted between 1
February and 31 March 2005, and the database of the
Health Directorate of Samsun province was used.
According to the database, ~76000 persons aged ≥ 40
years were living throughout the city center. From this
database, an age-stratified sample of 2326 men was
randomly selected and a total of 1860 (79.9%) men
participated in the study.
Together with a questionnaire including questions
pertaining to the respondents’ demographic
298
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characteristics, the Turkish version of the IPSS
validated by the Turkish Urological Association was
applied to all participants by face-to-face interview. The
IPSS comprises seven LUTS questions (incomplete
emptying, frequency, intermittency, urgency, poor
flow, hesitancy and nocturia) and one QoL question.
Each symptom was scored as a value of 0–5 (0, not at
all; 1, less than one time in five; 2, less than half the
time; 3, about half the time; 4, more than half the
time; and 5, almost always during the preceding
month). A symptom score of 0–35 was calculated by
adding the scores the patient gave to each of the seven
symptoms. An irritative symptom score was obtained
by adding the frequency, urgency and nocturia values,
while an obstructive score was calculated by adding the
scores of incomplete emptying, intermittency, weak
stream and straining symptoms. The symptom scores
were then categorized into four levels of severity from
‘none’ to ‘severe’ (0, none; 1–7, mild; 8–19, moderate;
and 20–35, severe).
The QoL question was utilized to score the overall
discomfort to patients caused by their current urinary
symptoms, from 0 to 6 (0, delighted; 1, pleased; 2,
mostly satisfied; 3, mixed [equally satisfied and
dissatisfied]; 4, mostly dissatisfied; 5, unhappy; and 6,
terrible).
The relationship between the IPSS and age was
modelled with linear regression analysis. For the nonlinear relation between age and the QoL score, since it
is an ordinal variable, and between IPSS and QoL score,
the Spearman’s non-parametric test was used.
Stepwise multiple regression analysis was used to
determine which symptom was the strongest predictor
of QoL. For the values not normally distributed, the
difference in IPSS and QoL between the age groups was
investigated by using Kruskal Wallis analyses of
variance followed by Bonferroni adjusted MannWhitney U test. Chi-square for trend analysis was used
for the difference in frequency of symptoms between
the age groups. Statistical significance was defined as a
probability of less than 0.05 except for the Bonferroni
adjusted Mann-Whitney U test, where a value <0.01
was used for significance.
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Results
The mean age of the respondents was 53.8 ± 10.0
years (range 40-89). The median IPSS and QoL were 3
(1-9) and 1 (0-3), and increased from 1.0 (0-4) and 0.0
(0-1) in the fifth decade to 18.0 (12-26.5) and 4.0 (3-5)
in those over 80, respectively. There were statistically
significant differences in both IPSS and QoL between the
age groups (P < 0.01). There were statistically significant
differences between the age groups, except between the
70-79 and ≥ 80 age groups, in severity score for all of
the symptoms, and the severity of all symptoms
significantly increased with age (P < 0.001). The only
statistically significant difference between the 70-79 and
≥ 80 age groups was found in the severity score of
nocturia (P < 0.01) (Table 1).
The increase with age was statistically significant and
there were moderate correlations between IPSS and age
(r = 0.54, r2 = 0.29, P < 0.001) and between QoL and
age (rs = 0.48, P < 0.001). There was also a strong
correlation between the IPSS and QoL scores (rs = 0.82,
P < 0.001).
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Of the participants, 81.3% had at least one
symptom. The frequency of having at least one symptom
increased from 68.6% in the fifth decade to 100.0% in
those over 80. The frequency was significantly lower in
the fifth decade than in the others (X2 = 145.1, df = 1,
P < 0.001). The most prevalent symptom was nocturia
(71.7%), followed by urination frequency (50.8%),
incomplete emptying of the bladder (44.3%), hesitancy
of urination (41.7%), poor urine flow (41.6%),
intermittency of urination (37.5%) and urgency of
urination (27.8%).
All symptoms were moderately correlated with each
other (rs = 0.51-0.69), except urgency and nocturia.
Among the seven symptoms in the IPSS, the correlation
with QoL was better with incomplete emptying (rs =
0.70), followed by poor flow (rs = 0.69) (Table 2).
Stepwise multiple regression analysis of the seven
symptoms in the IPSS showed nocturia to be the
strongest predictor of QoL (R2 = 0.50, P < 0.001).
If a total score of ≥ 8 is regarded as symptomatic(6),
551 (29.6%) of the respondents had moderate-to-severe

Table 1. The severity scores of each symptom in the IPSS per age group [median (25-75%) ].
Age Group
(Years)

Incomplete
Emptying

Frequency

Intermittency

Urgency

Poor Flow

Hesitancy

Nocturia

Total

QoL

40-49

0 (0-1)

0 (0-1)

0 (0-0)

0 (0-0)

0 (0-0)

0 (0-1)

1 (0-1)

1 (1-4)

0 (0-1)

50-59

0 (0-1)

1 (0-1)

0 (0-1)

0 (0-1)

0 (0-1)

0 (0-1)

1 (1-2)

4 (1-8)

1 (0-3)

60-69

1 (0-2)

1 (0-2)

1 (0-2)

0 (0-2)

1 (0-2)

1 (0-2)

2 (1-2)

8 (4-14)

2 (1-4)

70-79

2 (0-3.25)

2 (1-4)

2 (0-3)

1 (0-3)

2 (1-3)

1 (0-3)

2 (2-3)

13 (7-21)

3 (2-4)

≥ 80

3 (2-4.5)

3 (1.5-5)

3 (2-4)

2 (0.5-4)

3 (1-5)

3 (0.5-4.5)

3 (2-4)

18 (12-26.5)

4 (3-5)

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

P

Table 2. Spearman correlations between LUTS and QoL in the study group.

Incomplete Emptying
Frequency
Intermittency
Urgency
Poor Flow
Hesitancy
Nocturia

Incomplete
Emptying

Frequency

Intermittency

Urgency

Poor
Flow

Hesitancy

Nocturia

QoL

1.00

0.69

0.62

0.54

0.65

0.63

0.54

0.70

1.00

0.60

0.53

0.62

0.57

0.57

0.68

1.00

0.60

0.67

0.63

0.51

0.64

1.00

0.58

0.57

0.48

0.58

1.00

0.67

0.52

0.69

1.00

0.51

0.68

1.00

0.65
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LUTS as measured by the IPSS and the increase in the
prevalence of moderate-to-severe symptoms with age
was statistically important (χ2 = 405.8, df = 1, P <
0.001) (Table 3).
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perception of symptoms and evaluation of their effects on
the QoL among the participants of the two studies.
The prevalence of moderate-to-severe symptoms
(IPSS ≥ 8) found in this study (29.6%) was in the range
of prevalence (14-56%) found in different
countries(12,19,20) and similar with the prevalence
found in a previous study conducted in Turkey (24.9%)
(5). The prevalence of moderate-to-severe LUTS
according to age group is in accordance with the
literature for the 50-59 age group (28.2%), but was
higher in the 60-69 (52.9%) and 70-79 (72.4%) age
groups (10,11,15,16). The higher symptom prevalence
in the present study group may be a result of a low
tendency to seek treatment or may just reflect the racial
differences in IPSS.

Discussion
The present study provides a general picture of the
symptomatology profile of men over 40 years old in
Samsun.
In our study, while 18.7% of the participants were
asymptomatic, the rest (81.3%) had at least one
symptom. In the previous studies, the frequency of
asymptomatic participants varied between 9 and 18.8
(5,7-11). Andersson et al. (12) reported a ratio of 83%
with at least one symptom.

Although a high prevalence of men with moderate-tosevere LUTS and high correlation between the QoL and
total IPSS were found in the present study, only 43.7%
of symptomatic participants (IPSS ≥ 8) expressed
dissatisfaction (fairly bad, very bad or terrible perception)
about spending the rest of their lives with their current
urinary condition. This finding may be a reflection of
cultural habits of Turkish elders who regard LUTS as a
part of normal ageing.

With respect to the frequency of symptoms, the three
most frequent symptoms were nocturia (71.7%),
urination frequency (50.8%) and incomplete emptying of
the bladder (44.3%). While Perrin (13) reported weak
urinary stream, frequency and nocturia as the three most
frequent symptoms, Eckhardt (14) reported weak
urinary stream, frequency and urgency. On the other
hand, Aki et al. (5) reported similar results with our study
for the three most frequent symptoms. The prevalence of
nocturia was similar in almost all of the series (5,7,1518).

In conclusion, the results of this survey showed that
the prevalence of LUTS in Turkish elderly men is fairly
high, increases with age and has an impact on QoL that is
not negligible. The increasing prevalence of LUTS must be
considered when resources are planned for medical care
and, as LUTS adversely affect QoL, increased public
awareness is needed to combat a problem facing the
growing number of elderly men in the population.

In this study, incomplete emptying (rs = 0.70) was
found to be the best correlated with the QoL. Arvind et
al. (18) reported that weak stream (r = 0.52) was the
best correlated symptom with QoL in the IPSS. This
difference may be attributed to the differences in

Table 3. Overall and age-specific prevalence of LUTS.
Age
Group
(Years)

n

%*

n

%*

40-49

244

31.4

453

58.4

72

9.3

7

0.9

776

41.7

50-59

80

14.2

325

57.6

137

24.3

22

3.9

564

30.3

60-69

20

5.6

148

41.5

140

39.2

49

13.7

357

19.2

70-79

3

2.2

34

25.4

61

45.5

36

26.9

134

7.2

≥ 80

-

-

2

6.9

14

48.3

13

44.8

29

1.6

347

18.7

962

51.7

424

22.8

127

6.8

1860

100.0

TOTAL

None

*Row percent
**Column percent

300

Mild

Moderate
n

%*

Severe
n

%*

TOTAL
n

%**
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